Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer

Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer

BackgroundBone metastases (BoMs) are prevalent in patients with metastatic non-small-cell lung cancer (NSCLC) however, there are limited data detailing how BoMs respond to immune checkpoint inhibitors (ICIs). The purpose of this study was to compare the imaging response to ICIs of BoMs against visce...

Full description

Bibliographic Details
Main Authors: Annalise G. Abbott, Daniel E. Meyers, Golpira Elmi-Assadzadeh, Igor Stukalin, Alessandro Marro, Shannon K. T. Puloski, Don G. Morris, Winson Y. Cheung, Michael J. Monument
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Series:Frontiers in Immunology
Subjects:
non-small-cell lung cancer
bone
metastasis
checkpoint inhibitors
tumour microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1379056/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1379056/full

Similar Items